Personalized Immunotherapy for Autoimmune Diseases Market 2026 Top Players and Future Growth by 2035
Below is a structured market-insight framework for the Personalized Immunotherapy for Autoimmune Diseases Market, including real company references with numerical values, collaborations, or technology examples.
Personalized Immunotherapy for Autoimmune Diseases Market
1. Recent Developments
Eli Lilly and Company + Repertoire Immune Medicines
In 2026, Eli Lilly signed a collaboration worth up to $1.93 billion to develop precision immune-restoring therapies for autoimmune diseases using T-cell decoding technology.
https://www.thebrainyinsights.....com/report/personali